Arvee Laboratories (India) credit ratios

·UnclassifiedChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1.11.11.01.01.0
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
−2.2−2.2−4.9−6.5−2.3
0.03×0.03×0.03×0.03×0.04×
−0.06×−0.06×−0.16×−0.22×−0.08×
0.35×0.35×0.29×0.33×0.12×
−0.41×−0.68×−1.37×−2.18×−0.27×
8.45×8.45×9.90×6.00×16.33×
3.2%3.2%3.2%3.3%3.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ARVEE₹182.00

Arvee Laboratories (India) Limited

· Unclassified
₹ CrorePeersSPCENETGVPTECHMCLNITIRAJASPINWALLJMASINTERCOMMcap ₹201 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt1.01.01.01.11.1
Net Debt-2.3-6.5-4.9-2.2-2.2
Total Debt/Equity0.040.030.030.030.03
Net Debt/Equity-0.08-0.22-0.16-0.06-0.06
Total Debt/EBITDA0.120.330.290.350.35
Net Debt/EBITDA-0.27-2.18-1.37-0.68-0.41
Interest Coverage (EBIT/Interest)16.336.009.908.458.45
Total Debt/Total Capital %3.443.323.203.193.19
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.